Loading…
SEC insider activity covers quarterly filings through June 30, 2026. Later filings are not included. Reported roles do not establish current employment or current holdings. SEC filing documents, sections and filing-text search cover filings dated January 1, 2000 onward. Earlier filings are deferred until after launch.
Also known as: NOVOCURE
Firm Income Reported for This Client
$100K
Not substituted for client expenses
Summary
NOVOCURE is an organization, based in PA. Its political footprint includes $100K in lobbying-firm income reported for this client. Lobbying activity focuses on Trade (domestic/foreign), Tariff (miscellaneous tariff bills), Medical/Disease Research/Clinical Labs.